These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17785333)

  • 1. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
    De Paepe B; Creus KK; De Bleecker JL
    Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-chemokine receptor expression in idiopathic inflammatory myopathies.
    De Paepe B; De Bleecker JL
    Muscle Nerve; 2005 May; 31(5):621-7. PubMed ID: 15772970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
    De Paepe B; Schröder JM; Martin JJ; Racz GZ; De Bleecker JL
    Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
    Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Front Biosci; 2008 Jan; 13():2548-77. PubMed ID: 17981734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies.
    Civatte M; Bartoli C; Schleinitz N; Chetaille B; Pellissier JF; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):70-9. PubMed ID: 15634233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
    Figarella-Branger D; Civatte M; Bartoli C; Pellissier JF
    Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of chemokines in inflammatory myopathies.
    De Bleecker JL; De Paepe B; Vanwalleghem IE; Schröder JM
    Neurology; 2002 Jun; 58(12):1779-85. PubMed ID: 12084877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
    Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
    Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies.
    De Paepe B; Racz GZ; Schröder JM; De Bleecker JL
    Acta Neuropathol; 2004 Jul; 108(1):37-42. PubMed ID: 15138776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies.
    Lindberg C; Oldfors A; Tarkowski A
    Eur J Immunol; 1994 Nov; 24(11):2659-63. PubMed ID: 7957558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IL-18 production by dendritic cells in active inflammatory myopathies.
    Tucci M; Quatraro C; Dammacco F; Silvestris F
    Ann N Y Acad Sci; 2007 Jun; 1107():184-92. PubMed ID: 17804546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA; Visser LH; van Doorn PA; Savelkoul HF
    Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
    Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
    Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target.
    Crescioli C; Sottili M; Bonini P; Cosmi L; Chiarugi P; Romagnani P; Vannelli GB; Colletti M; Isidori AM; Serio M; Lenzi A; Di Luigi L
    Eur J Cell Biol; 2012 Feb; 91(2):139-49. PubMed ID: 22176919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.